| Group Q (n = 24) | Group QF (n = 26) | P-value |
---|---|---|---|
Postoperative 24 h sufentanil dosage(μg), (mean ± SD)a | 49.29 ± 16.76 | 31.42 ± 18.81 |  < 0.001* |
Sufentanil dosage at 6 h interval(μg), (mean ± SD)b | |||
  0–6 h | 2.71 ± 2.33 | 0 ± 0 | 0.122 |
  6–12 h | 8.20 ± 5.07 | 4.68 ± 3.67 | 0.044* |
  12–18 h | 18.89 ± 7.87 | 10.86 ± 7.65 |  < 0.001* |
  18–24 h | 19.48 ± 7.17 | 16.15 ± 9.34 | 0.058 |
  Remifentanil dosage(mg), (mean ± SD)a | 1.62 ± 0.52 | 1.17 ± 0.50 | 0.003* |
  Propofol dosage(mg), (mean ± SD)a | 337.08 ± 48.82 | 355.01 ± 52.78 | 0.230 |
  Time to removal of laryngeal mask(mins), (mean ± SD)a | 17.92 ± 5.98 | 10.58 ± 3.74 | 0.001* |
  Time to the first analgesic require(mins), (mean ± SD)c | 680.33 ± 311.95 | 1147.73 ± 351.93 |  < 0.001* |
  Number of use remedial analgesia, n(%)d | 7(29.2) | 2(7.69) | 0.063 |
  The incidence of PONV, n(%)d | 7(29.2) | 4(14.8) | 0.210 |